Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: A multi-institutional study

International Journal of Urology

Volumn 16, Issue 3, 2009, Pages 274-278

  Osawa, Takahiro ^a,b   Abe, Takashige ^a   Shinohara, Nobuo ^a   Harabayashi, Toru ^a   Sazawa, Ataru ^a   Kubota, Kanako ^c   Matsuno, Yoshihiro ^c   Shibata, Takeshi ^b   Shinno, Yuichiro ^b   Kamota, Shinji ^b   Minami, Keita ^b   Sakashita, Shigeo ^b   Kumagai, Akira ^b   Mori, Tatsuya ^b   Nonomura, Katsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hokkaido Urothelial Cancer Research Group   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adjuvant chemotherapy; Bladder cancer; Lymph node density; Lymph node metastasis; Prognosis

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL TIME; TIME SERIES ANALYSIS; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; CYSTECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 62149088507     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02221.x     Document Type: Article

References (21)

1. Herr HW, Bochner BH, Dalbagni G et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol. 2002 167 : 1295 8.
2. Lerner SP, Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol Clin. North Am. 1992 19 : 713 23.
3. Mills RD, Turner WH, Fleischmann A et al. Pelvic lymph node metastases from bladder cancer: Outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol. 2001 166 : 19 23.
4. Stein JP, Cai J, Groshen S et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: Concept of lymph node density. J. Urol. 2003 170 : 35 41.
5. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J. Urol. 2003 169 : 943 5.
6. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J. Urol. 2003 169 : 946 50.
7. Kassouf W, Leibovici D, Munsell MF et al. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J. Urol. 2006 176 : 53 7.
8. Lerner SP, Skinner DG, Lieskovsky G et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: Long-term results. J. Urol. 1993 149 : 758 64.
9. Leissner J, Hohenfellner R, Thüroff JW et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000 85 : 817 23.
10. Poulsen AL, Horn T, Steven K. Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J. Urol. 1998 160 : 2015 19.
11. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J. Urol. 2004 171 : 139 44.
12. Steven K, Poulsen AL. Radical cystectomy and extended pelvic lymphadenectomy: Survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J. Urol. 2007 178 : 1218 23.
13. Herr HW. The concept of lymph node density - is it ready for clinical practice? J. Urol. 2007 177 : 1273 5.
14. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why. Ann. Oncol. 2000 11 : 851 6.
15. Dreicer R. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: Current standards. Urol. Oncol. 2007 25 : 72 5.
16. Suzuki S, Shinohara N, Harabayashi T et al. Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer. Int. J. Urol. 2004 11 : 456 60.
17. Stockle M, Wellek S, Meyenburg W et al. Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: Prognostic impact of lymph node involvement. Urology 1996 48 : 868 75.
18. Park J, Park S, Song C et al. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Urology 2007 70 : 257 62.
19. Takahashi A, Tsukamoto T, Tobisu K et al. Radical cystectomy for invasive bladder cancer: Results of multi-institutional pooled analysis. Jpn J. Clin. Oncol. 2004 34 : 14 19.
20. Komai Y, Fujii Y, Okubo Y et al. Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy. Int. J. Urol. 2008 15 : 971 5.
21. Ruggeri EM, Giannarelli D, Bria E et al. Adjuvant chemotherapy in muscle-invasive bladder carcinoma: A pooled analysis from phase III studies. Cancer 2006 106 : 783 8.